UBS Maintains a 'Neutral' on Diodes (DIOD); Trim C12 EPS on Lower Gross Margins
DIOD Hot Sheet
Rating Summary:3 Buy, 7 Hold, 1 Sell
Rating Trend:
Down
Today's Overall Ratings:
Up: 19 | Down: 7 | New: 26
UBS maintains a 'Neutral' on Diodes (NASDAQ: DIOD) price target raised from $20 to $26.
UBS analyst says, "We are encouraged by Diodes’ position given stabilizing order trends and modest share gains in commodity discrete areas and do not view their pursuit of lower ASP and margin sales as having pricing implications for the long term. We view the lower capex spend near term as a positive as its fabs are modestly underutilized and gross margin improvement will occur as seasonal demand resumes."
"We model for Q1 sales of $146m while EPS is lowered to $0.10 from $0.15 on lower gross margin of 25.5% vs 27.5% previously. Our C12E sales increases slightly to $640m with EPS declining -14% to $0.97 from $1.13 on lower margins."
For an analyst ratings summary and ratings history on Diodes click here. For more ratings news on Diodes click here.
Shares of Diodes closed at $25.72 yesterday, with a 52 week range of $16.74-$34.67.
Discover Wall Street's best ratings calls with the pros - Ratings Insider Elite. Free Trial!
UBS analyst says, "We are encouraged by Diodes’ position given stabilizing order trends and modest share gains in commodity discrete areas and do not view their pursuit of lower ASP and margin sales as having pricing implications for the long term. We view the lower capex spend near term as a positive as its fabs are modestly underutilized and gross margin improvement will occur as seasonal demand resumes."
"We model for Q1 sales of $146m while EPS is lowered to $0.10 from $0.15 on lower gross margin of 25.5% vs 27.5% previously. Our C12E sales increases slightly to $640m with EPS declining -14% to $0.97 from $1.13 on lower margins."
For an analyst ratings summary and ratings history on Diodes click here. For more ratings news on Diodes click here.
Shares of Diodes closed at $25.72 yesterday, with a 52 week range of $16.74-$34.67.
Discover Wall Street's best ratings calls with the pros - Ratings Insider Elite. Free Trial!
You May Also Be Interested In
- Needham & Company Reiterates a 'Buy' on NetApp (NTAP); Solid 4Q Overshadowed by Conservative 1Q
- UBS Maintains a 'Buy' on Ralph Lauren (RL); Taking A More Conservative Approach
- Wells Fargo Upgrades Watson Pharmaceuticals (WPI) to Outperform; Actavis Acquisition Adds Growth Prospects
Create E-mail Alert Related Categories
Analyst Comments, Analyst EPS Change, Analyst EPS View, Analyst PT ChangeRelated Entities
UBSSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
